文献速递母胎医学产科

先天性巨细胞病毒感染且诊断时超声正常的胎儿结局:系统综述与荟萃分析

Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-03-09

该系统综述与荟萃分析纳入26项研究、2603例确诊先天性CMV感染胎儿,其中1178例(45.3%)诊断时超声正常。分析显示随访超声检出相关中枢神经系统异常率为4.4%,仅产前MRI检出率为5.8%,仅出生后影像检出率为3.2%;无异常检出者出生后症状性感染率1.5%,神经发育异常率3.1%,听力问题率6.5%。

要点

  • 超声正常先天性CMV胎儿随访超声检出CNS异常率4.4%(95%CI 1.4-8.8%)
  • 仅MRI检出CNS异常率5.8%(95%CI 1.9-11.5%),提示MRI有补充价值
  • 无异常检出者听力问题率6.5%(95%CI 3.8-10.0%),神经发育异常率3.1%

核心结论

  • 产前超声和MRI均未发现异常的先天性CMV感染胎儿,出生后不良结局风险低于既往未考虑产前影像评估的文献报告。
  • 即使超声正常,MRI仍可额外检出约6%的异常,提示MRI在产前评估中有潜在作用。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、EMBASE、CINAHL和Cochrane数据库。
  • 纳入26项研究,共2603例确诊先天性CMV感染胎儿,其中1178例(45.3%)诊断时超声正常并纳入分析。
  • 采用随机效应模型对比例进行荟萃分析,并按母体感染孕 trimester 进行亚组分析。

主要发现

  • 随访超声检出相关CNS异常率为4.4%(95%CI 1.4-8.8%)(32/523;15项研究)。
  • 仅产前MRI检出CNS异常率为5.8%(95%CI 1.9-11.5%)(19/357;11项研究)。
  • 仅出生后影像检出CNS异常率为3.2%(95%CI 0.3-9.0%)(50/660;17项研究)。
  • 随访超声检出相关非CNS异常率为2.9%(95%CI 0.8-6.3%)(19/523;15项研究),仅MRI检出率为0%(95%CI 0.0-1.7%)(0/357;11项研究),仅出生后影像检出率为0.9%(95%CI 0.3-1.8%)(4/660;17项研究)。
  • 宫内死亡和围产期死亡各为0.7%(95%CI 0.3-1.4%)(2/824;23项研究)。

临床怎么用

  • 对于先天性CMV感染且产前超声正常的胎儿,可依据本荟萃分析数据向孕妇提供更准确的预后咨询。
  • 即使超声未见异常,仍可考虑产前MRI以检出约6%仅MRI可见的异常。
  • 出生后需关注听力筛查和神经发育评估,因听力问题率6.5%、神经发育异常率3.1%。

局限性

  • 按母体感染孕 trimester 的亚组分析受纳入病例数很少及原始研究缺乏结局比较的限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the outcome of fetuses with congenital cytomegalovirus (CMV) infection and normal ultrasound at the time of diagnosis, and to evaluate the rate of an additional anomaly detected only on magnetic resonance imaging (MRI). METHODS: Medline, EMBASE, CINAHL and Cochrane databases were searched for studies reporting on the outcome of fetuses with congenital CMV infection. Inclusion criteria were fetuses with confirmed CMV infection and normal ultrasound assessment at the time of the initial evaluation. The outcomes observed were an anomaly detected on a follow-up ultrasound scan, an anomaly detected on prenatal MRI but missed on ultrasound, an anomaly detected on postnatal assessment but missed prenatally, perinatal mortality, symptomatic infection at birth, neurodevelopmental outcome and hearing and visual deficits. Neurodevelopmental outcome was assessed only in cases of isolated CMV infection confirmed at birth. Subgroup analysis was performed according to the trimester in which maternal infection occurred. Random-effects meta-analysis of proportions was used to analyze the data. RESULTS: Twenty-six studies were included, comprising 2603 fetuses with congenital CMV infection, of which 1178 (45.3%) had normal ultrasound at the time of diagnosis and were included in the analysis. The overall rate of an associated central nervous system (CNS) anomaly detected on a follow-up ultrasound scan was 4.4% (95% CI, 1.4-8.8%) (32/523; 15 studies), while the rates of those detected exclusively on prenatal MRI or on postnatal imaging were 5.8% (95% CI, 1.9-11.5%) (19/357; 11 studies) and 3.2% (95% CI, 0.3-9.0%) (50/660; 17 studies), respectively. The rate of an associated extra-CNS anomaly detected on a follow-up ultrasound scan was 2.9% (95% CI, 0.8-6.3%) (19/523; 15 studies), while the rates of those detected exclusively on MRI or on postnatal imaging were 0% (95% CI, 0.0-1.7%) (0/357; 11 studies) and 0.9% (95% CI, 0.3-1.8%) (4/660; 17 studies), respectively. Intrauterine death and perinatal death each occurred in 0.7% (95% CI, 0.3-1.4%) (2/824; 23 studies) of cases. In cases without an associated anomaly detected pre- or postnatally, symptomatic infection was found in 1.5% (95% CI, 0.7-2.7%) (6/548; 19 studies) of infants, the overall rate of a neurodevelopmental anomaly was 3.1% (95% CI, 1.6-5.1%) (16/550; 19 studies), and hearing problems affected 6.5% (95% CI, 3.8-10.0%) (36/550; 19 studies) of children. Subanalyses according to the trimester in which maternal infection occurred were affected by the very small number of included cases and lack of comparison of the observed outcomes in the original studies. Compared with fetuses infected in the second or third trimester, those infected in the first trimester had a relatively higher risk of having an additional anomaly detected on follow-up ultrasound or MRI, abnormal neurodevelopmental outcome and hearing problems. CONCLUSIONS: In fetuses with congenital CMV infection in which no anomalies are detected on prenatal ultrasound or MRI, the risk of adverse postnatal outcome is lower than that reported previously in the published literature when not considering the role of antenatal imaging assessment. The results from this review also highlight the potential role of MRI, even in fetuses with no anomalies detected on ultrasound, as an anomaly can be detected exclusively on MRI in about 6% of cases. The findings from this study could enhance prenatal counseling of pregnancies with congenital CMV infection with normal prenatal imaging. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Buca D, Di Mascio D, Rizzo G, et al. Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 33030767. doi:10.1002/uog.23143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。